Detalhe da pesquisa
1.
The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID-19 in the capital region of Denmark.
Diabetes Obes Metab
; 26(1): 160-168, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799010
2.
VEuPathDB: the eukaryotic pathogen, vector and host bioinformatics resource center.
Nucleic Acids Res
; 50(D1): D898-D911, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718728
3.
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Acta Oncol
; 62(12): 1653-1660, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874076
4.
Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial.
Diabetes Obes Metab
; 24(1): 142-147, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490741
5.
Acute changes in plasma glucose increases left ventricular systolic function in insulin-treated patients with type 2 diabetes and controls.
Diabetes Obes Metab
; 24(6): 1123-1131, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238140
6.
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Diabetologia
; 64(11): 2425-2431, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405256
7.
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity.
Expert Opin Emerg Drugs
; 26(3): 231-243, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176426
8.
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight.
Diabetes Obes Metab
; 23 Suppl 1: 17-35, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621414
9.
Dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3-30)NH2 on GIP actions in humans.
Diabetes Obes Metab
; 23(1): 68-74, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886401
10.
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
Diabetologia
; 62(4): 665-675, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683945
11.
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.
Int J Mol Sci
; 20(17)2019 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31443356
12.
GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.
Diabetologia
; 61(2): 413-423, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28948296
13.
Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial.
Clin Chem Lab Med
; 56(12): 2047-2057, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30004900
14.
Genome of Rhodnius prolixus, an insect vector of Chagas disease, reveals unique adaptations to hematophagy and parasite infection.
Proc Natl Acad Sci U S A
; 112(48): 14936-41, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26627243
15.
Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity.
Diabetes Obes Metab
; 24(9): 1882-1887, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491518
16.
Quality of care for people with multimorbidity - a case series.
BMC Health Serv Res
; 17(1): 745, 2017 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151022
17.
Pancreatic polypeptide: A potential biomarker of glucose-dependent insulinotropic polypeptide receptor activation in vivo.
Diabet Med
; 38(8): e14592, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33955602
18.
Safety of native glucose-dependent insulinotropic polypeptide in humans.
Peptides
; 177: 171214, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615716
19.
The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity.
Endocr Connect
; 13(3)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38276866
20.
Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake.
STAR Protoc
; 4(1): 102070, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853704